Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
An Effectiveness Trial of Project ALERT
This study has been completed.
Sponsored by: Pacific Institute for Research and Evaluation
Information provided by: Pacific Institute for Research and Evaluation
ClinicalTrials.gov Identifier: NCT00650585
  Purpose

The purpose of this study is to replicate a longitudinal evaluation of Project ALERT, a substance abuse prevention program that targets middle school students.


Condition Intervention
Alcohol Drinking
Smoking
Marijuana Smoking
Behavioral: Project ALERT

MedlinePlus related topics: Alcohol Consumption Marijuana Smoking Smoking and Youth
Drug Information available for: Cannabis GW-1000 Ethanol
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind (Subject), Parallel Assignment, Efficacy Study
Official Title: Promising Programs for Substance Abuse Prevention: Replication and Evaluation Initiative

Further study details as provided by Pacific Institute for Research and Evaluation:

Primary Outcome Measures:
  • Substance use (30-day and lifetime use of alcohol, marijuana, cigarettes, inhalants) [ Time Frame: measured approximately 30 days after intervention completed and 1 year later ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Mediators of substance use (resistance self-efficacy, beliefs about drug use consequences, perceived peer influence, expectations of future use) [ Time Frame: measured approximately 30 days after intervention completed and 1 year later ] [ Designated as safety issue: No ]

Enrollment: 6043
Study Start Date: May 2004
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Control group: No Intervention
Did not receive Project ALERT
Treatment group: Experimental
Received Project ALERT
Behavioral: Project ALERT
Project ALERT (Adolescent Learning Experiences in Resistance Training) is a drug prevention curriculum designed for middle-school students (11 to 14 years old). The 11 lessons in the first year and 3 booster lessons in the second year focus on alcohol, tobacco, marijuana, and inhalants - the substances that adolescents are most likely to use. Project ALERT uses participatory activities and videos to help motivate youth to avoid drug use, to teach youth skills and strategies to resist peer pressures to use drugs, and to establish social norms against drug-use. More information about Project ALERT may be found at http://www.projectalert.best.org/.

Detailed Description:

Project ALERT is a substance abuse prevention program that targets middle school students. The purposes of this evaluation are to test its immediate and one-year effectiveness in a randomized experimental design that will span a total of 2.5 years for each of two cohorts. The cohorts are spaced one year apart to reduce our implementation and data collection burdens at any one time. The design for the two cohorts is identical. In schools randomly assigned to the treatment group, instructors receive Project ALERT training and materials prior to beginning the program and have access to technical assistance on request. In schools randomly assigned to the control group, teachers implement whatever substance abuse prevention curricula they normally would (if any).

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • schools with 6th-8th grades housed together on a common campus
  • schools with 6th grade student population of at least 100 students
  • schools with no current 6th, 7th, or 8th grade implementation of any drug prevention curriculum recognized as a model program by a federally-sponsored registry
  • all regular education students in the targeted grade must participate

Exclusion Criteria:

  • students in self-contained classrooms (i.e., special education classes)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00650585

Locations
United States, North Carolina
Pacific Institute for Research & Evaluation
Chapel Hill, North Carolina, United States, 27514
Sponsors and Collaborators
Pacific Institute for Research and Evaluation
Investigators
Principal Investigator: Chris L Ringwalt, DrPH Pacific Institute for Research & Evaluation
Study Director: Heddy K Clark, Ph.D. Pacific Institute for Research & Evaluation
  More Information

Project ALERT website  This link exits the ClinicalTrials.gov site

Responsible Party: Pacific Institute for Research & Evaluation ( Chris Ringwalt/Senior Research Scientist )
Study ID Numbers: 2003-DR-FX-001, 2007-JF-FX-0064
Study First Received: March 31, 2008
Last Updated: October 9, 2008
ClinicalTrials.gov Identifier: NCT00650585  
Health Authority: United States: Institutional Review Board

Keywords provided by Pacific Institute for Research and Evaluation:
smoking
alcohol
prevention
prevention & control

Study placed in the following topic categories:
Smoking
Drinking Behavior
Alcohol Drinking
Marijuana Smoking
Marijuana Abuse
Ethanol

Additional relevant MeSH terms:
Habits

ClinicalTrials.gov processed this record on January 16, 2009